Hold Dr Lal PathLabs, says Vijay Chopra

Vijay Chopra of enochventures.com told CNBC-TV18, "I think people for listing gains, have sold the stock of Dr Lal Pathlabs although the company is good and the kind of network this company has across the country and the kind of health awareness which is going around in our country, this is a good story and a buyable story.""I think it can go down to Rs 750-760 and that could be a level where it can settle down and consolidate and from there we will see the upmove coming, but as of now hold on to the stock. I do not see much panic in it because people are just booking profits due to the fantastic listing it had," he added.